dba

SARS-CoV-2 (COVID-19, 2019-nCoV) Reagents

SARS CoV 2 (COVID-19) Patient Sample Validated Antibodies| ProSci Inc. 

SARS-CoV-2 (COVID-19) Virus Antibody Research

ProSci Incorporated has developed and manufactured SARS-CoV-2 (COVID-19, 2019-nCoV) antibodies, antigens, and other reagents related to cellular entry: ACE2 receptor, TMPRSSR2 protease, and furin enzyme. ProSci Inc. is continuously adding new SARS-CoV-2 reagents for spike, S1, S2, nucleocapsid, membrane, envelope including llama single domain antibodies and recombinant proteins.

SARS-CoV-2 Featured Products

 

  COVID-19 Patient Validated 

Cat. No: 9099 SARS-CoV-2 (COVID-19) Nucleocapsid Antibody

Cat. No: 9083 SARS-CoV-2 (COVID-19) Spike S1 Antibody

SARS-CoV-2 (COVID-19) 9099 Nucleocapsid Protein IHC on COVID-19 Patient Lung | ProSci Inc.

  COVID-19 Patient Validated  

Cat. No: 3525 SARS-CoV-2 (COVID-19) Spike Antibody

COVID-19 (SARS-CoV-2) Patient Spike Protein IHC Validated | ProSci Inc.

  COVID-19 Patient Validated  

Cat. No: 3531 SARS-CoV-2 (COVID-19) Envelope Antibody

COVID-19 (SARS-CoV-2) 3531 Spike Protein ELISA | ProSci Inc.


For a complete list of SARS-CoV-2 research product portfolio, visit us at prosci-inc.com


 

Richiedi un'offerta

DBA-ITALIA Srl
Via Umbria 10
20054 Segrate (Milano)

Tel. +39 02-26922300
Fax +39 02-26926058
Fax +39 02-26923535




If you no longer wish to receive these announcements click here